Australia's most trusted
source of pharma news
Posted 2 March 2026 AM
Generic Health has become the first company to register a generic of Pharmaco’s antipsychotic medicine Zyprexa IM under two brand names - Olanzapine GM IM and Olanzapine Lupin IM.
Administered via intramuscular injection and registered on the ARTG back in 2001, Zyprexa IM is indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia and related psychoses and in patients with acute mania associated with Bipolar 1 Disorder, when oral therapy is not appropriate. The drug is not listed on the PBS.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.